Osterweis Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Sell
4,431
-79
-2% -$18.4K 0.06% 99
2025
Q4
$933K Buy
4,510
+79
+2% +$15.6K 0.04% 106
2025
Q3
$822K Hold
4,431
0.04% 106
2025
Q2
$677K Sell
4,431
-2,555
-37% -$393K 0.03% 109
2025
Q1
$1.16M Sell
6,986
-431
-6% -$67.4K 0.06% 99
2024
Q4
$1.07M Sell
7,417
-30
-0.4% -$4.65K 0.05% 105
2024
Q3
$1.21M Hold
7,447
0.06% 103
2024
Q2
$1.09M Sell
7,447
-20
-0.3% -$2.97K 0.06% 102
2024
Q1
$1.18M Sell
7,467
-2,962
-28% -$471K 0.07% 96
2023
Q4
$1.63M Hold
10,429
0.1% 93
2023
Q3
$1.62M Sell
10,429
-171,479
-94% -$28.3M 0.12% 90
2023
Q2
$30.1M Buy
181,908
+4,142
+2% +$669K 1.99% 19
2023
Q1
$27.6M Sell
177,766
-496
-0.3% -$80.1K 1.87% 19
2022
Q4
$31.5M Buy
178,262
+5,783
+3% +$999K 2.29% 8
2022
Q3
$28.2M Sell
172,479
-609
-0.4% -$103K 2.11% 11
2022
Q2
$30.7M Sell
173,088
-2,178
-1% -$388K 2.3% 11
2022
Q1
$31.1M Sell
175,266
-4,220
-2% -$718K 1.71% 16
2021
Q4
$30.7M Sell
179,486
-5,607
-3% -$918K 1.54% 23
2021
Q3
$29.9M Buy
185,093
+876
+0.5% +$149K 1.63% 19
2021
Q2
$30.3M Buy
184,217
+11,315
+7% +$1.87M 1.56% 23
2021
Q1
$28.4M Buy
172,902
+5,715
+3% +$925K 1.55% 24
2020
Q4
$26.3M Sell
167,187
-1,527
-0.9% -$225K 1.57% 28
2020
Q3
$25.1M Sell
168,714
-10,571
-6% -$1.56M 1.7% 21
2020
Q2
$25.2M Sell
179,285
-16,165
-8% -$2.36M 1.83% 14
2020
Q1
$25.6M Sell
195,450
-8,458
-4% -$1.2M 2.08% 14
2019
Q4
$29.7M Buy
203,908
+66,819
+49% +$9.06M 2.06% 12
2019
Q3
$17.7M Buy
137,089
+582
+0.4% +$76.7K 1.29% 37
2019
Q2
$19M Sell
136,507
-3,857
-3% -$534K 1.34% 32
2019
Q1
$19.6M Buy
140,364
+48
+0% +$6.43K 1.23% 33
2018
Q4
$18.1M Sell
140,316
-14,673
-9% -$2.05M 1.39% 32
2018
Q3
$21.4M Sell
154,989
-45,810
-23% -$6.09M 1.37% 32
2018
Q2
$24.4M Sell
200,799
-882
-0.4% -$110K 1.58% 28
2018
Q1
$25.8M Sell
201,681
-3,707
-2% -$501K 1.84% 21
2017
Q4
$28.7M Buy
205,388
+1,514
+0.7% +$211K 2.04% 24
2017
Q3
$26.5M Sell
203,874
-6,596
-3% -$874K 1.99% 22
2017
Q2
$27.8M Sell
210,470
-1,875
-0.9% -$239K 2.12% 24
2017
Q1
$26.4M Sell
212,345
-63,419
-23% -$7.58M 2.07% 21
2016
Q4
$31.8M Sell
275,764
-239,467
-46% -$27.7M 2.29% 20
2016
Q3
$60.9M Sell
515,231
-79,658
-13% -$9.66M 3.66% 6
2016
Q2
$72.2M Sell
594,889
-83,217
-12% -$9.46M 4.6% 5
2016
Q1
$73.4M Buy
678,106
+157,445
+30% +$16.3M 4.26% 10
2015
Q4
$53.5M Sell
520,661
-366,044
-41% -$36.8M 4.92% 4
2015
Q3
$82.8M Sell
886,705
-5,117
-0.6% -$495K 3.75% 7
2015
Q2
$86.9M Sell
891,822
-109,390
-11% -$11M 3.03% 12
2015
Q1
$101M Sell
1,001,212
-19,835
-2% -$2.02M 3.22% 9
2014
Q4
$107M Sell
1,021,047
-45,927
-4% -$4.84M 3.5% 8
2014
Q3
$114M Sell
1,066,974
-15,485
-1% -$1.61M 3.49% 4
2014
Q2
$113M Sell
1,082,459
-7,607
-0.7% -$769K 3.24% 6
2014
Q1
$107M Buy
1,090,066
+7,665
+0.7% +$711K 3.28% 4
2013
Q4
$99.1M Sell
1,082,401
-666
-0.1% -$61.4K 3.07% 8
2013
Q3
$100M Sell
1,083,067
-43,777
-4% -$3.93M 3.24% 4
2013
Q2
$96.8M Buy
+1,126,844
New +$95.6M 3.61% 3

Other funds holding JNJ

Osterweis Capital Management's JNJ Position: Q1 2026 in Review

Osterweis Capital Management reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q1 2026, selling an estimated $18.4K and leaving 4,431 shares worth $1.08M. The position accounts for 0.06% of the portfolio, ranked #99.

Osterweis Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $114M in Q3 2014. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Osterweis Capital Management held 4,431 shares of Johnson & Johnson worth $1.08M as of Q1 2026.
  • Osterweis Capital Management sold 79 Johnson & Johnson shares in Q1 2026, an estimated $18.4K.
  • Johnson & Johnson made up 0.06% of Osterweis Capital Management's portfolio in Q1 2026, its #99 holding.
  • Osterweis Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Osterweis Capital Management's Johnson & Johnson position peaked at $114M in Q3 2014.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Osterweis Capital Management's 13F filing for Q1 2026, filed 15 May 2026.